Metabolic shift in lung alveolar cell mitochondria following acrolein exposure

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 305, Issue 10, 2013, Pages

  Agarwal, Amit R ^a   Yin, Fei ^a   Cadenas, Enrique ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Glycolysis; Palmitate; Pulmonary surfactant

Indexed keywords

ACROLEIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PHOSPHOLIPASE A2;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CYTOTOXICITY; ENERGY METABOLISM; ENERGY YIELD; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; RAT; UPREGULATION;

GLYCOLYSIS; PALMITATE; PULMONARY SURFACTANT;

ACROLEIN; ADENOCARCINOMA; ANIMALS; CELL RESPIRATION; CELL SURVIVAL; CELLS, CULTURED; EPITHELIAL CELLS; FLOW CYTOMETRY; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLYCOLYSIS; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED A; MITOCHONDRIA; OXYGEN CONSUMPTION; PALMITATES; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2; PULMONARY ALVEOLI; RATS;

EID: 84887584933     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00165.2013     Document Type: Article

References (52)

1. Agarwal AR, Zhao L, Sancheti H, Sundar IK, Rahman I, Cadenas E. Short-term cigarette smoke exposure induces reversible changes in energy metabolism and cellular redox status independent of inflammatory responses in mouse lungs. Am J Physiol Lung Cell Mol Physiol 303: L889-L898, 2012.
2. Agassandian M, Mallampalli RK. Surfactant phospholipid metabolism. Biochim Biophys Acta 1831: 612-625, 2013.
3. Anderson EJ, Katunga LA, Willis MS. Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clin Exp Pharmacol Physiol 39: 179-193, 2012.
4. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 97: 517-523, 1959.
5. Bassett DJP, Hamosh M, Hamosh P, Rabinowitz JL. Pathways of palmitate metabolism in the isolated rat lung. Exp Lung Res 2: 37-47, 1981.
6. Chung FL, Young R, Hecht SS. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res 44: 990-995, 1984.
7. Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 128: S42-S46, 1983.
8. Demaio L, Tseng W, Balverde Z, Alvarez JR, Kim KJ, Kelley DG, Senior RM, Crandall ED, Borok Z. Characterization of mouse alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 296: L1051-L1058, 2009.
9. Dong L, Zhou S, Yang X, Chen Q, He Y, Huang W. Magnolol protects against oxidative stress-mediated neural cell damage by modulating mitochondrial dysfunction and PI3K/Akt signaling. J Mol Neurosci 50: 469-481, 2013.
10. Eiserich JP, van der Vliet A, Handelman GJ, Halliwell B, Cross CE. Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 62: 1490S-1500S, 1995.
11. Evans MJ, Cabral LJ, Stephens RJ, Freeman G. Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol 22: 142-150, 1975.
12. Feng Z, Liu Z, Li X, Jia H, Sun L, Tian C, Jia L, Liu J. alpha-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells. J Nutr Biochem 21: 1222-1231, 2010.
13. Finkelstein EI, Nardini M, van der Vliet A. Inhibition of neutrophil apoptosis by acrolein: a mechanism of tobacco-related lung disease? Am J Physiol Lung Cell Mol Physiol 281: L732-L739, 2001.
14. Fischer A. Intermediary metabolism of the lung. Environ Health Perspect 55: 149-158, 1984.
15. Fukuda T, Kim DK, Chin MR, Hales CA, Bonventre JV. Increased group IV cytosolic phospholipase A2 activity in lungs of sheep after smoke inhalation injury. Am J Physiol Lung Cell Mol Physiol 277: L533-L542, 1999.
16. Hirama N, Shibata Y, Otake K, Machiya J, Wada T, Inoue S, Abe S, Takabatake N, Sata M, Kubota I. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema. Respirology 12: 191-201, 2007.
17. Hohlfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airways disease. Eur Respir J 10: 482-491, 1997.
18. Horton ND, Mamiya BM, Kehrer JP. Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology 122: 111-122, 1997.
19. Jia L, Liu Z, Sun L, Miller SS, Ames BN, Cotman CW, Liu J. Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in rpe cells: protection by (R)--lipoic acid. Invest Ophthalmol Vis Sci 48: 339-348, 2007.
20. Jia L, Zhang Z, Zhai L, Bai Y. Protective effect of lipoic acid against acrolein-induced cytotoxicity in IMR-90 human fibroblasts. J Nutr Sci Vitaminol 55: 126-130, 2009. 79-95, 2002.
21. Kern JC, Kehrer JP. Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem-Biol Interact 139: 79-95, 2002.
22. Lam CW, Casanova M, Heck HD. Depletion of nasal mucosal glutathione by acrolein and enhancement of formaldehyde-induced DNA-protein cross-linking by simultaneous exposure to acrolein. Arch Toxicol 58: 67-71, 1985.
23. Li L, Hamilton RF Jr, Holian A. Effect of acrolein on human alveolar macrophage NF-kappaB activity. Am J Physiol Lung Cell Mol Physiol 277: L550-L557, 1999.
24. Liu Z, Sun L, Zhu L, Jia X, Li X, Jia H, Wang Y, Weber P, Long J, Liu J. Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem 103: 2690-2700, 2007.
25. Luo J, Shi R. Acrolein induces oxidative stress in brain mitochondria. Neurochem Int 46: 243-252, 2005.
26. Macklin CC. The pulmonary alveolar mucoid film and the pneumonocytes. Lancet 266: 1099-1104, 1954.
27. Martyniuk CJ, Fang B, Koomen JM, Gavin T, Zhang L, Barber DS, Lopachin RM. Molecular mechanism of glyceraldehyde-3-phosphate dehydrogenase inactivation by alpha,beta-unsaturated carbonyl derivatives. Chem Res Toxicol 24: 2302-2311, 2011.
28. Mohammad MK, Avila D, Zhang J, Barve S, Arteel G, McClain C, Joshi-Barve S. Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress. Toxicol Appl Pharmacol 265: 73-82, 2012.
29. Moon KY. Acrolein, an I-kappaBalpha-independent downregulator of NF-kappaB activity, causes the decrease in nitric oxide production in human malignant keratinocytes. Arch Toxicol 85: 499-504, 2011.
30. More JM, Voelker DR, Silveira LJ, Edwards MG, Chan ED, Bowler RP. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease (Abstract). BMC Pulm Med 10: 53, 2010.
31. Nakamura M, Tomitori H, Suzuki T, Sakamoto A, Terui Y, Saiki R, Dohmae N, Igarashi K, Kashiwagi K. Inactivation of GAPDH as one mechanism of acrolein toxicity. Biochem Biophys Res Commun 430: 1265-1271, 2013.
32. Ohlmeier S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, Myllarniemi M, Kinnula VL. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 7: 5125-5132, 2008.
33. Pandolfi PP, Sonati F, Rivi R, Mason P, Grosveld F, Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J 14: 5209-5215, 1995.
34. Picklo MJ, Montine TJ. Acrolein inhibits respiration in isolated brain mitochondria. Biochim Biophys Acta 1535: 145-152, 2001.
35. Pocernich CB, Butterfield DA. Acrolein inhibits NADH-linked mitochondrial enzyme activity: implications for Alzheimer's disease. Neurotox Res 5: 515-520, 2003.
36. Ralser M, Wamelink MM, Latkolik S, Jansen EE, Lehrach H, Jakobs C. Metabolic reconfiguration precedes transcriptional regulation in the antioxidant response. Nat Biotechnol 27: 604-605, 2009.
37. Rhoades RA. Influence of starvation on the lung: effect on glucose and palmitate utilization. J Appl Physiol 38: 513-516, 1975.
38. Rooney SA. Lung surfactant. Environ Health Perspect 55: 205-226, 1984.
39. Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 8: 957-967, 1994.
40. Roy J, Pallepati P, Bettaieb A, Averill-Bates DA. Acrolein induces apoptosis through the death receptor pathway in A549 lung cells: role of p53. Can J Physiol Pharmacol 88: 353-368, 2010.
41. Rudra PK, Krokan HE. Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid sensitive and resistant human tumor cells. Anticancer Res 19: 461-469, 1999.
42. Sakata K, Kashiwagi K, Sharmin S, Ueda S, Irie Y, Murotani N, Igarashi K. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 305: 143-149, 2003.
43. Sarkar P, Hayes BE. Proteomic profiling of rat lung epithelial cells induced by acrolein. Life Sci 85: 188-195, 2009.
44. Slater AF, Stefan C, Nobel I, van den Dobbelsteen DJ, Orrenius S. Intracellular redox changes during apoptosis. Cell Death Differ 3: 57-62, 1996.
45. Stevens JF, Maier CS. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 52: 7-25, 2008.
46. Sun L, Luo C, Long J, Wei D, Liu J. Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion 6: 136-142, 2006.
47. Tanel A, Averill-Bates DA. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta 1743: 255-267, 2005.
48. Tanel A, Averill-Bates DA. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J Pharmacol Exp Ther 321: 73-83, 2007.
49. Watanabe M, Sugimoto M, Ito K. The acrolein cytotoxicity and cytoprotective action of alpha-tocopherol in primary cultured rat hepatocytes. Gastroenterol Jpn 27: 199-205, 1992.
50. Wu J, Stevens JF, Maier CS. Mass spectrometry-based quantification of myocardial protein adducts with acrolein in an in vivo model of oxidative stress. Mol Nutr Food Res 55: 1401-1410, 2011.
51. Yoval-Sanchez B, Rodriguez-Zavala JS. Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts. Chem Res Toxicol 25: 722-729, 2012.
52. Yu SH, Possmayer F. Lipid compositional analysis of pulmonary surfactant monolayers and monolayer-associated reservoirs. J Lipid Res 44: 621-629, 2003.